Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
about
MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinomaComparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCCKIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinsesMicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass indexUpdated overview of current biomarkers in head and neck carcinomaNovel DNA methylation targets in oral rinse samples predict survival of patients with oral squamous cell carcinomaOutlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients.Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinseAberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancerAdvances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of CancerTKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilizationThe Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical MarginsEndothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.Promoter hypermethylation in Indian primary oral squamous cell carcinoma.A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinomaOral squamous cell cancer: early detection and the role of alcohol and smoking.A review of research on salivary biomarkers for oral cancer detection.Serum biomarkers for detection of head and neck squamous cell carcinoma.NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva.Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice.Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminomaDetection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas.The role of MAGEA2 in head and neck cancer.Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinomaMethylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance.Methylation-mediated molecular dysregulation in clinical oral malignancyCorrelation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer.DNA methylation profiles and biomarkers of oral squamous cell carcinoma.CpG island methylation profile in non-invasive oral rinse samples is predictive of oral and pharyngeal carcinoma.Salivary biomarker development using genomic, proteomic and metabolomic approaches.Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative studyMethylated DNA and microRNA in body fluids as biomarkers for cancer detection.Evaluation of p16 hypermethylation in oral submucous fibrosis: A quantitative and comparative analysis in buccal cells and saliva using real-time methylation-specific polymerase chain reaction.EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatmentThe context and potential of epigenetics in oncologyEnvironmental exposure measurement in cancer epidemiology.
P2860
Q21134039-EF61BB23-A4C6-408B-A063-2D322A8901B9Q21561014-FD2824A1-2FEE-4122-AD92-A82430A0E996Q24600000-896AD81B-DBAC-4B40-9073-396E6212F961Q24628888-73AE7E8C-4540-48F2-9108-C918651DC72BQ26750659-02BCC94F-DB64-4A27-9E13-C2CF7DA9F288Q28383468-4C3E099E-6C0B-4530-A358-A0D5410DC908Q30278379-AE96B692-813F-4BE9-9AED-94D86F2A9AC5Q33511047-ECF4ADFE-9DF6-47D0-93FC-58CF7B12CA6FQ33596504-F38EF1E3-1308-42DB-8225-FB796D3E3C15Q33610394-2203B812-331F-4701-AF2B-2F56B2B232B8Q33624423-51840945-18D5-4586-B667-476BD19D2764Q33668662-D741CC43-83FB-43BC-9933-BE3B440F1AA7Q33741519-62795184-5E34-4276-A9EA-E6ACF525D614Q34153823-367A7F29-3055-4036-82E0-846C60F18BD3Q34159082-701AEC1D-AECE-4664-8854-F5860C9DC592Q34200303-07185514-E274-4569-A070-543139ECA936Q34500198-6B9E1F2D-6260-4555-AFA9-EF31103494BBQ34659915-E0208FF4-230E-4559-91B8-17CD8009307EQ35050148-CEA1DB6C-E1E4-4848-945C-38AA876E48FDQ35091263-8F71EFC1-D967-4500-99E3-45650FEAE735Q35143147-72E334E6-13E3-43F0-83B6-AA795D822F53Q35547513-59514BAB-9362-42B8-BF35-A9F53839BA5FQ35682021-B3F6532B-0263-4430-8B59-93D45823F4FDQ35784536-4ED9239D-DE2D-4680-A46A-D7467A37D737Q35792884-31522D18-8494-497E-A201-6725B95940A3Q35844503-1ED0034E-D182-4617-95AB-555D91FE87F7Q35881912-355802B0-11BC-4FDA-8D02-0847BF087757Q35925441-06D4CE58-6DA8-4831-9CCA-614AE7CFA034Q35974424-D1D6569A-F545-4890-B022-DCAB72FA88F8Q36149220-53F09D0E-6D6C-4F67-97FD-98C0A5A183E4Q36213267-14755601-842C-4487-B671-E584977157C2Q36344111-FCE72C34-44B5-43C3-86C4-729E250730A5Q36632967-54085534-886D-400C-86A8-D8FF7FF229D9Q36812119-D8EBA2C0-6F76-4D25-BE0A-C521BF2F0117Q36913739-29FA5089-943C-47C0-9C92-386F4644933AQ36918927-52BA59AF-14BC-4922-89EF-A548DECBA480Q36941462-BF47303A-3CB7-45B6-AE3C-2F52632CDB77Q36988805-EC3170B8-BD9B-4737-8E6D-07152E7F2CE6Q37123413-BDDB98D9-95DA-42AF-BC5C-0C2F13E41458Q37288804-CB18061F-48FE-4ABD-A5E9-8DCA006B3EF4
P2860
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Evaluation of promoter hyperme ...... neck squamous cell carcinoma.
@en
type
label
Evaluation of promoter hyperme ...... neck squamous cell carcinoma.
@en
prefLabel
Evaluation of promoter hyperme ...... neck squamous cell carcinoma.
@en
P2093
P50
P1476
Evaluation of promoter hyperme ...... d neck squamous cell carcinoma
@en
P2093
André Lopes Carvalho
Chetan S Nayak
Chul-so Moon
David Goldenberg
David Sidransky
Elizabeth Garrett-Mayer
Joseph A Califano
Michael M Kim
Quia Claybourne
P304
P356
10.1158/1078-0432.CCR-07-0722
P407
P577
2008-01-01T00:00:00Z